{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T22:58:18Z","timestamp":1793141898329,"version":"4.5.0"},"reference-count":160,"publisher":"Bentham Science Publishers Ltd.","issue":"7","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["MC"],"published-print":{"date-parts":[[2025,8]]},"abstract":"<jats:sec>\n<jats:title\/>\n<jats:p>Although platinum and ruthenium complexes have been clinically recognized to be the\nmost efficient metal-based anticancer candidates, applied in a wide range of cancer cell lines, their\nserious toxic effects and drug resistance require the necessity for new metal antitumor complexes.\nThere is excessive interest in the design of new Pt-group metal complexes, including osmium and\nrhodium, which have revealed great chemotherapeutic potential. They have demonstrated modes of\naction that differ from those of the most broadly-used in clinical practice platinum- and rutheniumbased\ncompounds. Os and Rh complexes are equipotent to their platinum and ruthenium analogues.\nMany Os- and Rh-based complexes with strong antitumor activity and low toxic effects have been\ndeveloped and recognized for their antineoplastic activity in the last few years. Some of them have\nexposed different action profiles from the conventional anticancer metal complexes. That is why\nthey might serve as a possible alternative that deserves more investigation, though limited studies\non their biological effects have been reported, which is in contrast with the classical isoelectronic Pt\nand Ru complex compounds. Studies of Os and Rh complexes are currently attracting scientific\nattention. Recent developments of this interesting class of novel chemotherapeutic agents have been\nreviewed.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0115734064327558240826050650","type":"journal-article","created":{"date-parts":[[2024,9,2]],"date-time":"2024-09-02T01:09:38Z","timestamp":1725239378000},"page":"619-645","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Recent Advances in Anticancer Research of Osmium and Rhodium Complexes"],"prefix":"10.2174","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6290-7327","authenticated-orcid":true,"given":"Irena","family":"Kostova","sequence":"first","affiliation":[{"name":"Department of Chemistry, Faculty of Pharmacy, Medical University-Sofia, 2 Dunav St., Sofia 1000, Bulgaria"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.jorganchem.2017.03.038","volume":"839","author":"Zhang P.","year":"2017","unstructured":"Zhang P.; Sadler P.J.; Advances in the design of organometallic anticancer complexes. J Organomet Chem  2017,839,5-14","journal-title":"J Organomet Chem"},{"key":"ref=2","doi-asserted-by":"publisher","DOI":"10.2174\/97898151790021230101","author":"Kostova I.","year":"2023","unstructured":"Kostova I.;  Biological and Medical Significance of Chemical Elements  2023","journal-title":"Biological and Medical Significance of Chemical Elements"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"56","DOI":"10.3390\/inorganics11020056","volume":"11","author":"Kostova I.","year":"2023","unstructured":"Kostova I.; The role of complexes of biogenic metals in living organisms. Inorganics (Basel)  2023,11(2),56","journal-title":"Inorganics (Basel)"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.3390\/molecules28041959","volume":"28","author":"Todorov L.","year":"2023","unstructured":"Todorov L.; Kostova I.; Recent trends in the development of novel metal-based antineoplastic drugs. Molecules  2023,28(4),1959","journal-title":"Molecules"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"214307","DOI":"10.1016\/j.ccr.2021.214307","volume":"452","author":"Paprocka R.","year":"2022","unstructured":"Paprocka R.; Wiese-Szadkowska M.; Janciauskiene S.; Kosmalski T.; Kulik M.; Helmin-Basa A.; Latest developments in metal complexes as anticancer agents. Coord Chem Rev  2022,452,214307","journal-title":"Coord Chem Rev"},{"key":"ref=6","doi-asserted-by":"publisher","DOI":"10.1515\/9781501516115","author":"Goswami A.K.","year":"2022","unstructured":"Goswami A.K.; Kostova I.;  Medicinal and Biological Inorganic Chemistry  2022","journal-title":"Medicinal and Biological Inorganic Chemistry"},{"key":"ref=7","first-page":"1","volume":"1","author":"Kostova I.","year":"2006","unstructured":"Kostova I.; Platinum complexes as anticancer agents. Recent Pat. Rev. Anti \u2013Canc. Drug Disc  2006,1(1),1-22","journal-title":"Drug Disc"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.2174\/092986706776360941","volume":"13","author":"Kostova I.","year":"2006","unstructured":"Kostova I.; Ruthenium complexes as anticancer agents. Curr Med Chem  2006,13(9),1085-1107","journal-title":"Curr Med Chem"},{"key":"ref=9","first-page":"137366","volume":"19","author":"Shahlaei M.","year":"2023","unstructured":"Shahlaei M.; Asl S.M.; Derakhshani A.; Kurek L.; Karges J.; Macgregor R.; Kostova I.; Saboury A.A.; Platinum-based drugs in cancer treatment: expanding horizons and overcoming resistance. J Mol Struct  2023,19,137366","journal-title":"J Mol Struct"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"106","DOI":"10.5306\/wjco.v7.i1.106","volume":"7","author":"Kilari D.","year":"2016","unstructured":"Kilari D.; Guancial E.; Kim E.S.; Role of copper transporters in platinum resistance. World J Clin Oncol  2016,7(1),106-113","journal-title":"World J Clin Oncol"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/1471-2407-8-175","volume":"8","author":"Kalayda G.V.","year":"2008","unstructured":"Kalayda G.V.; Wagner C.H.; Bu\u00df I.; Reedijk J.; Jaehde U.; Altered localisation of the copper efflux transporters ATP7A and ATP7B associated with cisplatin resistance in human ovarian carcinoma cells. BMC Cancer  2008,8(1),175","journal-title":"BMC Cancer"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"5496","DOI":"10.1038\/s41598-021-84185-x","volume":"11","author":"Rodrigo M.A.M.","year":"2021","unstructured":"Rodrigo M.A.M.; Michalkova H.; Strmiska V.; Casar B.; Crespo P.; de los Rios V.; Ignacio Casal J.; Haddad Y.; Guran R.; Eckschlager T.; Pokorna P.; Heger Z.; Adam V.; Metallothionein-3 promotes cisplatin chemoresistance remodelling in neuroblastoma. Sci Rep  2021,11(1),5496","journal-title":"Sci Rep"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1080\/15592294.2020.1834926","volume":"16","author":"Fazal Z.","year":"2021","unstructured":"Fazal Z.; Singh R.; Fang F.; Bikorimana E.; Baldwin H.; Corbet A.; Tomlin M.; Yerby C.; Adra N.; Albany C.; Lee S.; Freemantle S.J.; Nephew K.P.; Christensen B.C.; Spinella M.J.; Hypermethylation and global remodelling of DNA methylation is associated with acquired cisplatin resistance in testicular germ cell tumours. Epigenetics  2021,16(10),1071-1084","journal-title":"Epigenetics"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"7241","DOI":"10.3390\/ijms23137241","volume":"23","author":"Ali R.","year":"2022","unstructured":"Ali R.; Aouida M.; Alhaj Sulaiman A.; Madhusudan S.; Ramotar D.; Can Cisplatin therapy be improved? Pathways that can be targeted. Int J Mol Sci  2022,23(13),7241","journal-title":"Int J Mol Sci"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"6645","DOI":"10.1039\/C8DT00838H","volume":"47","author":"Oun R.","year":"2018","unstructured":"Oun R.; Moussa Y.E.; Wheate N.J.; The side effects of platinum-based chemotherapy drugs: a review for chemists. Dalton Trans  2018,47(19),6645-6653","journal-title":"Dalton Trans"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"9934","DOI":"10.1039\/C8DT01858H","volume":"47","author":"Konkankit C.C.","year":"2018","unstructured":"Konkankit C.C.; Marker S.C.; Knopf K.M.; Wilson J.J.; Anticancer activity of complexes of the third row transition metals, rhenium, osmium, and iridium. Dalton Trans  2018,47(30),9934-9974","journal-title":"Dalton Trans"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"146","DOI":"10.3390\/ph12040146","volume":"12","author":"Riccardi C.","year":"2019","unstructured":"Riccardi C.; Musumeci D.; Trifuoggi M.; Irace C.; Paduano L.; Montesarchio D.; Anticancer ruthenium(III) complexes and Ru(III)-containing nanoformulations: an update on the mechanism of action and biological activity. Pharmaceuticals (Basel)  2019,12(4),146","journal-title":"Pharmaceuticals (Basel)"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"1086267","DOI":"10.3389\/fchem.2023.1086267","volume":"11","author":"Kacsir I.","year":"2023","unstructured":"Kacsir I.; Sipos A.; Kiss T.; Major E.; Bajusz N.; T\u00f3th E.; Bugly\u00f3 P.; Soms\u00e1k L.; Kardos G.; Bai P.; Bokor \u00c9.; Half sandwich-type osmium, ruthenium, iridium and rhodium complexes with bidentate glycosyl heterocyclic ligands induce cytostasis in platinum-resistant ovarian cancer cells and bacteriostasis in Gram-positive multiresistant bacteria. Front Chem  2023,11,1086267","journal-title":"Front Chem"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"20008","DOI":"10.1021\/acs.inorgchem.2c03279","volume":"61","author":"Hu X.","year":"2022","unstructured":"Hu X.; Guo L.; Liu M.; Zhang Q.; Gong Y.; Sun M.; Feng S.; Xu Y.; Liu Y.; Liu Z.; Increasing anticancer activity with phosphine ligation in zwitterionic half-sandwich iridium (III), rhodium (III), and ruthenium (II) complexes. Inorg Chem  2022,61(49),20008-20025","journal-title":"Inorg Chem"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"20140185","DOI":"10.1098\/rsta.2014.0185","volume":"373","author":"Johnstone T.C.","year":"2015","unstructured":"Johnstone T.C.; Suntharalingam K.; Lippard S.J.; Third row transition metals for the treatment of cancer. Philos Trans- Royal Soc, Math Phys Eng Sci  2015,373(2037),20140185","journal-title":"Philos Trans- Royal Soc, Math Phys Eng Sci"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"214790","DOI":"10.1016\/j.ccr.2022.214790","volume":"472","author":"Su\u00e1rez-Moreno G.V.","year":"2022","unstructured":"Su\u00e1rez-Moreno G.V.; Hern\u00e1ndez-Romero D.; Garc\u00eda-Barradas \u00d3.; V\u00e1zquez-Vera \u00d3.; Rosete-Luna S.; Cruz-Cruz C.A.; L\u00f3pez-Monteon A.; Carrillo-Ahumada J.; Morales-Morales D.; Colorado-Peralta R.; Second and third-row transition metal compounds containing benzimidazole ligands: An overview of their anticancer and antitumour activity. Coord Chem Rev  2022,472,214790","journal-title":"Coord Chem Rev"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1021\/acs.chemrev.8b00271","volume":"119","author":"Kenny R.G.","year":"2019","unstructured":"Kenny R.G.; Marmion C.J.; Toward multi-targeted platinum and ruthenium drugs\u2014a new paradigm in cancer drug treatment regimens? Chem Rev  2019,119(2),1058-1137","journal-title":"Chem Rev"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3390\/inorganics7030031","volume":"7","author":"Coverdale J.P.C.","year":"2019","unstructured":"Coverdale J.P.C.; Laroiya-McCarron T.; Romero-Canel\u00f3n I.; Designing ruthenium anticancer drugs: What have we learnt from the key drug candidates? Inorganics (Basel)  2019,7(3),31","journal-title":"Inorganics (Basel)"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jinorgbio.2016.10.001","volume":"169","author":"Milutinovic M.M.","year":"2017","unstructured":"Milutinovic M.M.; Rilak A.; Bratsos I.; Klisuric O.; Vrane\u0161 M.; Gligorijevic N.; Radulovic S.; Bugarcic Z.D.; New 40-(4-chlorophenyl)-2,2\u2032:60,200-terpyridine ruthenium(II) complexes: Synthesis, characterization, interaction with DNA\/BSA and cytotoxicity studies. J Inorg Biochem  2017,169,1-12","journal-title":"J Inorg Biochem"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1007\/s00775-017-1479-7","volume":"22","author":"\u010canovi\u0107 P.","year":"2017","unstructured":"\u010canovi\u0107 P.; Simovi\u0107 A.R.; Radisavljevi\u0107 S.; Bratsos I.; Demitri N.; Mitrovi\u0107 M.; Zelen I.; Bugar\u010di\u0107 \u017d.D.; Impact of aromaticity on anticancer activity of polypyridyl ruthenium(II) complexes: synthesis, structure, DNA\/protein binding, lipophilicity and anticancer activity. J Biol Inorg Chem  2017,22(7),1007-1028","journal-title":"J Biol Inorg Chem"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1007\/s13738-015-0804-8","volume":"13","author":"Jahromi E.Z.","year":"2016","unstructured":"Jahromi E.Z.; Divsalar A.; Saboury A.A.; Khaleghizadeh S.; Mansouri-Torshizi H.; Kostova I.; Palladium complexes: new candidates for anti-cancer drugs. J Indian Chem Soc  2016,13(5),967-989","journal-title":"J Indian Chem Soc"},{"key":"ref=27","author":"Pelclova D.","year":"2022","unstructured":"Pelclova D.;  Handbook on the Toxicology of Metals  2022","journal-title":"Handbook on the Toxicology of Metals"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1111\/bcpt.13450","volume":"127","author":"Friedova N.","year":"2020","unstructured":"Friedova N.; Pelclova D.; Obertova N.; Lach K.; Kesslerova K.; Kohout P.; Osmium absorption after osmium tetroxide skin and eye exposure. Basic Clin Pharmacol Toxicol  2020,127(5),429-433","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.freeradbiomed.2004.10.027","volume":"38","author":"Goldstein S.","year":"2005","unstructured":"Goldstein S.; Czapski G.; Heller A.; Osmium tetroxide, used in the treatment of arthritic joints, is a fast mimic of superoxide dismutase. Free Radic Biol Med  2005,38(7),839-845","journal-title":"Free Radic Biol Med"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1016\/j.drudis.2014.06.016","volume":"19","author":"Hanif M.","year":"2014","unstructured":"Hanif M.; Babak M.V.; Hartinger C.G.; Development of anticancer agents: wizardry with osmium. Drug Discov Today  2014,19(10),1640-1648","journal-title":"Drug Discov Today"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"39","DOI":"10.12688\/openreseurope.14595.2","volume":"2","author":"Quinson J.","year":"2022","unstructured":"Quinson J.; Osmium and OsOx nanoparticles: an overview of syntheses and applications. Open Research Europe  2022,2,39","journal-title":"Open Research Europe"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"2245","DOI":"10.1038\/s41467-022-29969-z","volume":"13","author":"Lu N.","year":"2022","unstructured":"Lu N.; Deng Z.; Gao J.; Liang C.; Xia H.; Zhang P.; An osmium-peroxo complex for photoactive therapy of hypoxic tumors. Nat Commun  2022,13(1),2245","journal-title":"Nat Commun"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"11120","DOI":"10.1039\/C8CC06427J","volume":"54","author":"Ortega E.","year":"2018","unstructured":"Ortega E.; Yellol J.G.; Rothemund M.; Ballester F.J.; Rodr\u00edguez V.; Yellol G.; Janiak C.; Schobert R.; Ruiz J.; A new C,N-cyclometalated osmium(II) arene anticancer scaffold with a handle for functionalization and antioxidative properties. Chem Commun (Camb)  2018,54(79),11120-11123","journal-title":"Chem Commun (Camb)"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/978-1-60327-459-3_10","author":"van Rijt S.H.","year":"2009","unstructured":"van Rijt S.H.; Peacock A.F.A.; Sadler P.J.;  In: Platinum and Other Heavy Metal Compounds in Cancer Chemotherapy Molecular Mechanisms and Clinical Applications  2009,73-79","journal-title":"In: Platinum and Other Heavy Metal Compounds in Cancer Chemotherapy Molecular Mechanisms and Clinical Applications"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"9246","DOI":"10.1021\/acs.jmedchem.8b00958","volume":"61","author":"Coverdale J.P.C.","year":"2018","unstructured":"Coverdale J.P.C.; Bridgewater H.E.; Song J.I.; Smith N.A.; Barry N.P.E.; Bagley I.; Sadler P.J.; Romero-Canel\u00f3n I.; In vivo selectivity and localization of reactive oxygen species (ROS) induction by osmium anticancer complexes that circumvent platinum resistance. J Med Chem  2018,61(20),9246-9255","journal-title":"J Med Chem"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1039\/C9QI01148J","volume":"7","author":"Licona C.","year":"2020","unstructured":"Licona C.; Delhorme J.B.; Riegel G.; Vidimar V.; Cer\u00f3n-Camacho R.; Boff B.; Venkatasamy A.; Tomasetto C.; da Silva Figueiredo Celestino Gomes P.; Rognan D.; Freund J-N.; Le Lagadec R.; Pfeffer M.; Gross I.; Mellitzer G.; Gaiddon C.; Anticancer activity of ruthenium and osmium cyclometalated compounds: identification of ABCB1 and EGFR as resistance mechanisms. Inorg Chem Front  2020,7(3),678-688","journal-title":"Inorg Chem Front"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1021\/ja055886r","volume":"128","author":"Peacock A.F.A.","year":"2006","unstructured":"Peacock A.F.A.; Habtemariam A.; Fern\u00e1ndez R.; Walland V.; Fabbiani F.P.A.; Parsons S.; Aird R.E.; Jodrell D.I.; Sadler P.J.; Tuning the reactivity of osmium(II) and ruthenium(II) arene complexes under physiological conditions. J Am Chem Soc  2006,128(5),1739-1748","journal-title":"J Am Chem Soc"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"4049","DOI":"10.1021\/ic062350d","volume":"46","author":"Peacock A.F.A.","year":"2007","unstructured":"Peacock A.F.A.; Habtemariam A.; Moggach S.A.; Prescimone A.; Parsons S.; Sadler P.J.; Chloro half-sandwich osmium(II) complexes: influence of chelated N,N-ligands on hydrolysis, guanine binding, and cytotoxicity. Inorg Chem  2007,46(10),4049-4059","journal-title":"Inorg Chem"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"3348","DOI":"10.1021\/ja068335p","volume":"129","author":"Peacock A.F.A.","year":"2007","unstructured":"Peacock A.F.A.; Parsons S.; Sadler P.J.; Tuning the hydrolytic aqueous chemistry of osmium arene complexes with N,O-chelating ligands to achieve cancer cell cytotoxicity. J Am Chem Soc  2007,129(11),3348-3357","journal-title":"J Am Chem Soc"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1002\/chem.200601152","volume":"13","author":"Peacock A.F.A.","year":"2007","unstructured":"Peacock A.F.A.; Melchart M.; Deeth R.J.; Habtemariam A.; Parsons S.; Sadler P.J.; Osmium(II) and ruthenium(II) arene maltolato complexes: rapid hydrolysis and nucleobase binding. Chemistry  2007,13(9),2601-2613","journal-title":"Chemistry"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"3635","DOI":"10.1021\/jm701538w","volume":"51","author":"Kostrhunova H.","year":"2008","unstructured":"Kostrhunova H.; Florian J.; Novakova O.; Peacock A.F.A.; Sadler P.J.; Brabec V.; DNA interactions of monofunctional organometallic osmium(II) antitumor complexes in cell-free media. J Med Chem  2008,51(12),3635-3643","journal-title":"J Med Chem"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1021\/ic8020222","volume":"48","author":"van Rijt S.H.","year":"2009","unstructured":"van Rijt S.H.; Peacock A.F.A.; Johnstone R.D.L.; Parsons S.; Sadler P.J.; Organometallic osmium(II) arene anticancer complexes containing picolinate derivatives. Inorg Chem  2009,48(4),1753-1762","journal-title":"Inorg Chem"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"6643","DOI":"10.1021\/om700813c","volume":"26","author":"Schmid W.F.","year":"2007","unstructured":"Schmid W.F.; John R.O.; Arion V.B.; Jakupec M.A.; Keppler B.K.; Highly antiproliferative ruthenium(II) and osmium(II) arene complexes with paullone-derived ligands. Organometallics  2007,26(26),6643-6652","journal-title":"Organometallics"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1021\/om049022a","volume":"24","author":"Dorcier A.","year":"2005","unstructured":"Dorcier A.; Dyson P.J.; Gossens C.; Rothlisberger U.; Scopelliti R.; Tavernelli I.; Binding of organometallic ruthenium(II) and osmium(II) complexes to an oligonucleotide: a combined mass spectrometric and theoretical study. Organometallics  2005,24(9),2114-2123","journal-title":"Organometallics"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.jorganchem.2005.08.041","volume":"691","author":"Chan K.H.","year":"2006","unstructured":"Chan K.H.; Leong W.K.; Jaouen G.; Leclerq L.; Top S.; Vessi\u00e8res A.; Organometallic cluster analogues of tamoxifen: Synthesis and biochemical assay. J Organomet Chem  2006,691(1-2),9-19","journal-title":"J Organomet Chem"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"8192","DOI":"10.1021\/jm100560f","volume":"53","author":"Fu Y.","year":"2010","unstructured":"Fu Y.; Habtemariam A.; Pizarro A.M.; van Rijt S.H.; Healey D.J.; Cooper P.A.; Shnyder S.D.; Clarkson G.J.; Sadler P.J.; Organometallic osmium arene complexes with potent cancer cell cytotoxicity. J Med Chem  2010,53(22),8192-8196","journal-title":"J Med Chem"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"E3800","DOI":"10.1073\/pnas.1500925112","volume":"112","author":"Hearn J.M.","year":"2015","unstructured":"Hearn J.M.; Romero-Canel\u00f3n I.; Munro A.F.; Fu Y.; Pizarro A.M.; Garnett M.J.; McDermott U.; Carragher N.O.; Sadler P.J.; Potent organo-osmium compound shifts metabolism in epithelial ovarian cancer cells. Proc Natl Acad Sci USA  2015,112(29),E3800-E3805","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"2512","DOI":"10.1002\/chem.201605911","volume":"23","author":"Sanchez-Cano C.","year":"2017","unstructured":"Sanchez-Cano C.; Romero-Canel\u00f3n I.; Yang Y.; Hands-Portman I.J.; Bohic S.; Cloetens P.; Sadler P.J.; Synchrotron X\u2010ray fluorescence nanoprobe reveals target sites for organo\u2010osmium complex in human ovarian cancer cells. Chemistry  2017,23(11),2512-2516","journal-title":"Chemistry"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1002\/anie.201610290","volume":"56","author":"Needham R.J.","year":"2017","unstructured":"Needham R.J.; Sanchez-Cano C.; Zhang X.; Romero-Canel\u00f3n I.; Habtemariam A.; Cooper M.S.; Meszaros L.; Clarkson G.J.; Blower P.J.; Sadler P.J.; In\u2010cell activation of organo\u2010osmium(II) anticancer complexes. Angew Chem Int Ed  2017,56(4),1017-1020","journal-title":"Angew Chem Int Ed"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"8909","DOI":"10.1002\/anie.201602995","volume":"55","author":"Fu Y.","year":"2016","unstructured":"Fu Y.; Romero M.J.; Salassa L.; Cheng X.; Habtemariam A.; Clarkson G.J.; Prokes I.; Rodger A.; Costantini G.; Sadler P.J.; Os 2 \u2013Os 4 switch controls DNA knotting and anticancer activity. Angew Chem Int Ed  2016,55(31),8909-8912","journal-title":"Angew Chem Int Ed"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"6273","DOI":"10.1021\/ic400555k","volume":"52","author":"B\u00fcchel G.E.","year":"2013","unstructured":"B\u00fcchel G.E.; Gavriluta A.; Novak M.; Meier S.M.; Jakupec M.A.; Cuzan O.; Turta C.; Tommasino J.B.; Jeanneau E.; Novitchi G.; Luneau D.; Arion V.B.; Striking difference in antiproliferative activity of ruthenium- and osmium-nitrosyl complexes with azole heterocycles. Inorg Chem  2013,52(11),6273-6285","journal-title":"Inorg Chem"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"5023","DOI":"10.1021\/ic700405y","volume":"46","author":"Cebri\u00e1n-Losantos B.","year":"2007","unstructured":"Cebri\u00e1n-Losantos B.; Krokhin A.A.; Stepanenko I.N.; Eichinger R.; Jakupec M.A.; Arion V.B.; Keppler B.K.; Osmium NAMI-A analogues: synthesis, structural and spectroscopic characterization, and antiproliferative properties. Inorg Chem  2007,46(12),5023-5033","journal-title":"Inorg Chem"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"7690","DOI":"10.1021\/ic200728b","volume":"50","author":"B\u00fcchel G.E.","year":"2011","unstructured":"B\u00fcchel G.E.; Stepanenko I.N.; Hejl M.; Jakupec M.A.; Keppler B.K.; Arion V.B.; En route to osmium analogues of KP1019: synthesis, structure, spectroscopic properties and antiproliferative activity of trans-[Os(IV)Cl4(Hazole)2. Inorg Chem  2011,50(16),7690-7697","journal-title":"Inorg Chem"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"11130","DOI":"10.1021\/ic501710k","volume":"53","author":"Kuhn P.S.","year":"2014","unstructured":"Kuhn P.S.; B\u00fcchel G.E.; Jovanovi\u0107 K.K.; Filipovi\u0107 L.; Radulovi\u0107 S.; Rapta P.; Arion V.B.; Osmium(III) analogues of KP1019: electrochemical and chemical synthesis, spectroscopic characterization, X-ray crystallography, hydrolytic stability, and antiproliferative activity. Inorg Chem  2014,53(20),11130-11139","journal-title":"Inorg Chem"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"3398","DOI":"10.1021\/jm3000906","volume":"55","author":"Ginzinger W.","year":"2012","unstructured":"Ginzinger W.; M\u00fchlgassner G.; Arion V.B.; Jakupec M.A.; Roller A.; Galanski M.S.; Reithofer M.; Berger W.; Keppler B.K.; A SAR study of novel antiproliferative ruthenium and osmium complexes with quinoxalinone ligands in human cancer cell lines. J Med Chem  2012,55(7),3398-3413","journal-title":"J Med Chem"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"11715","DOI":"10.1021\/ic201704u","volume":"50","author":"Stepanenko I.N.","year":"2011","unstructured":"Stepanenko I.N.; Novak M.S.; M\u00fchlgassner G.; Roller A.; Hejl M.; Arion V.B.; Jakupec M.A.; Keppler B.K.; Organometallic 3-(1H-benzimidazol-2-yl)-1H-pyrazolo[3,4-b]pyridines as potential anticancer agents. Inorg Chem  2011,50(22),11715-11728","journal-title":"Inorg Chem"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"14060","DOI":"10.1021\/ja4075375","volume":"135","author":"Suntharalingam K.","year":"2013","unstructured":"Suntharalingam K.; Johnstone T.C.; Bruno P.M.; Lin W.; Hemann M.T.; Lippard S.J.; Bidentate ligands on osmium(VI) nitrido complexes control intracellular targeting and cell death pathways. J Am Chem Soc  2013,135(38),14060-14063","journal-title":"J Am Chem Soc"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"14413","DOI":"10.1021\/ja508808v","volume":"136","author":"Suntharalingam K.","year":"2014","unstructured":"Suntharalingam K.; Lin W.; Johnstone T.C.; Bruno P.M.; Zheng Y.R.; Hemann M.T.; Lippard S.J.; A breast cancer stem cell-selective, mammospheres-potent osmium(VI) nitrido complex. J Am Chem Soc  2014,136(41),14413-14416","journal-title":"J Am Chem Soc"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"13327","DOI":"10.1038\/s41598-019-49774-x","volume":"9","author":"Novohradsky V.","year":"2019","unstructured":"Novohradsky V.; Markova L.; Kostrhunova H.; Tr\u00e1vn\u00ed\u010dek Z.; Brabec V.; Kasparkova J.; An anticancer Os(II) bathophenanthroline complex as a human breast cancer stem cell-selective, mammosphere potent agent that kills cells by necroptosis. Sci Rep  2019,9(1),13327","journal-title":"Sci Rep"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"12341","DOI":"10.1039\/C7CC07776A","volume":"53","author":"Zhang P.","year":"2017","unstructured":"Zhang P.; Wang Y.; Qiu K.; Zhao Z.; Hu R.; He C.; Zhang Q.; Chao H.; A NIR phosphorescent osmium(II) complex as a lysosome tracking reagent and photodynamic therapeutic agent. Chem Commun (Camb)  2017,53(91),12341-12344","journal-title":"Chem Commun (Camb)"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"2705","DOI":"10.1021\/ic302779q","volume":"52","author":"Boff B.","year":"2013","unstructured":"Boff B.; Gaiddon C.; Pfeffer M.; Cancer cell cytotoxicity of cyclometalated compounds obtained with osmium(II) complexes. Inorg Chem  2013,52(5),2705-2715","journal-title":"Inorg Chem"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"16341","DOI":"10.1021\/acs.inorgchem.0c02137","volume":"59","author":"Roque J.A.","year":"2020","unstructured":"Roque J.A.; Barrett P.C.; Cole H.D.; Lifshits L.M.; Bradner E.; Shi G.; von Dohlen D.; Kim S.; Russo N.; Deep G.; Cameron C.G.; Alberto M.E.; McFarland S.A.; Os(II) oligothienyl complexes as a hypoxia-active photosensitizer class for photodynamic therapy. Inorg Chem  2020,59(22),16341-16360","journal-title":"Inorg Chem"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"9784","DOI":"10.1039\/D0SC03008B","volume":"11","author":"Roque J.A.","year":"2020","unstructured":"Roque J.A.; Barrett P.C.; Cole H.D.; Lifshits L.M.; Shi G.; Monro S.; von Dohlen D.; Kim S.; Russo N.; Deep G.; Cameron C.G.; Alberto M.E.; McFarland S.A.; Breaking the barrier: an osmium photosensitizer with unprecedented hypoxic phototoxicity for real world photodynamic therapy. Chem Sci (Camb)  2020,11(36),9784-9806","journal-title":"Chem Sci (Camb)"},{"key":"ref=64","doi-asserted-by":"crossref","first-page":"213888","DOI":"10.1016\/j.ccr.2021.213888","volume":"438","author":"Huang L.I.","year":"2021","unstructured":"Huang L.I.; Zhao S.; Wu J.; Yu L.E.; Singh N.; Yang K.E.; Lan M.; Wang P.; Kim J.S.; Photodynamic therapy for hypoxic tumors: Advances and perspectives. Coord Chem Rev  2021,438,213888","journal-title":"Coord Chem Rev"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"4020","DOI":"10.1039\/D0QI00846J","volume":"7","author":"Ge C.","year":"2020","unstructured":"Ge C.; Zhu J.; Ouyang A.; Lu N.; Wang Y.; Zhang Q.; Zhang P.; Near-infrared phosphorescent terpyridine osmium(II) photosensitizer complexes for photodynamic and photooxidation therapy. Inorg Chem Front  2020,7(20),4020-4027","journal-title":"Inorg Chem Front"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"11749","DOI":"10.1039\/D3SC03932C","volume":"14","author":"Wang Y.","year":"2023","unstructured":"Wang Y.; Mesdom P.; Purkait K.; Saubam\u00e9a B.; Burckel P.; Arnoux P.; Frochot C.; Cariou K.; Rossel T.; Gasser G.; Ru(II)\/Os(II)-based carbonic anhydrase inhibitors as photodynamic therapy photosensitizers for the treatment of hypoxic tumours. Chem Sci (Camb)  2023,14(42),11749-11760","journal-title":"Chem Sci (Camb)"},{"key":"ref=67","doi-asserted-by":"publisher","DOI":"10.5772\/intechopen.88519","author":"Kaspler P.","year":"2020","unstructured":"Kaspler P.; Mandel A.; Dumoulin-White R.; Roufaiel M.;  In: Tumor Progression and Metastasis  2020","journal-title":"In: Tumor Progression and Metastasis"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"e202218347","DOI":"10.1002\/anie.202218347","volume":"62","author":"Mani A.","year":"2023","unstructured":"Mani A.; Feng T.; Gandioso A.; Vinck R.; Notaro A.; Gourdon L.; Burckel P.; Saubam\u00e9a B.; Blacque O.; Cariou K.; Belgaied J.E.; Chao H.; Gasser G.; Structurally simple osmium (II) polypyridyl complexes as photosensitizers for photodynamic therapy in the near infrared. Angew Chem Int Ed  2023,62(20),e202218347","journal-title":"Angew Chem Int Ed"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"43479","DOI":"10.1021\/acsami.3c08503","volume":"15","author":"Wang Y.P.","year":"2023","unstructured":"Wang Y.P.; Duan X.H.; Huang Y.H.; Hou Y.J.; Wu K.; Zhang F.; Pan M.; Shen J.; Su C.Y.; Radio- and Photosensitizing Os(II)-Based Nanocage for Combined Radio-\/Chemo-\/X-ray-Induced Photodynamic Therapies, NIR Imaging, and Drug Delivery. ACS Appl Mater Interfaces  2023,15(37),43479-43491","journal-title":"ACS Appl Mater Interfaces"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"114233","DOI":"10.1016\/j.jpba.2021.114233","volume":"204","author":"Armstrong D.W.","year":"2021","unstructured":"Armstrong D.W.; Yu J.; Cole H.D.; McFarland S.A.; Nafie J.; Chiral resolution and absolute configuration determination of new metal-based photodynamic therapy antitumor agents. J Pharm Biomed Anal  2021,204,114233","journal-title":"J Pharm Biomed Anal"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/php.13467","volume":"98","author":"Smith C.B.","year":"2022","unstructured":"Smith C.B.; Days L.C.; Alajroush D.R.; Faye K.; Khodour Y.; Beebe S.J.; Holder A.A.; Photodynamic therapy of inorganic complexes for the treatment of cancer. Photochem Photobiol  2022,98(1),17-41","journal-title":"Photochem Photobiol"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"1900139","DOI":"10.1002\/adtp.201900139","volume":"3","author":"Felder P.S.","year":"2020","unstructured":"Felder P.S.; Keller S.; Gasser G.; Polymetallic complexes for applications as photosensitisers in anticancer photodynamic therapy. Adv Ther (Weinh)  2020,3(1),1900139","journal-title":"Adv Ther (Weinh)"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"113308","DOI":"10.1016\/j.ejmech.2021.113308","volume":"216","author":"Sohrabi M.","year":"2021","unstructured":"Sohrabi M.; Saeedi M.; Larijani B.; Mahdavi M.; Recent advances in biological activities of rhodium complexes: Their applications in drug discovery research. Eur J Med Chem  2021,216,113308","journal-title":"Eur J Med Chem"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"26","DOI":"10.3390\/inorganics9040026","volume":"9","author":"M\u00e1likov\u00e1 K.","year":"2021","unstructured":"M\u00e1likov\u00e1 K.; Masaryk L.; \u0160tarha P.; Anticancer half-sandwich rhodium (III) complexes. Inorganics (Basel)  2021,9(4),26","journal-title":"Inorganics (Basel)"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"215231","DOI":"10.1016\/j.ccr.2023.215231","volume":"490","author":"Prathima T.S.","year":"2023","unstructured":"Prathima T.S.; Choudhury B.; Ahmad M.G.; Chanda K.; Balamurali M.M.; Recent developments on other platinum metal complexes as target-specific anticancer therapeutics. Coord Chem Rev  2023,490,215231","journal-title":"Coord Chem Rev"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.ica.2012.06.046","volume":"393","author":"Geldmacher Y.","year":"2012","unstructured":"Geldmacher Y.; Oleszak M.; Sheldrick W.S.; Rhodium(III) and iridium(III) complexes as anticancer agents. Inorg Chim Acta  2012,393,84-102","journal-title":"Inorg Chim Acta"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"14855","DOI":"10.1039\/C8DT03032D","volume":"47","author":"Ohata J.","year":"2018","unstructured":"Ohata J.; Ball Z.T.; Rhodium at the chemistry\u2013biology interface. Dalton Trans  2018,47(42),14855-14860","journal-title":"Dalton Trans"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"213999","DOI":"10.1016\/j.ccr.2021.213999","volume":"442","author":"Loreto D.","year":"2021","unstructured":"Loreto D.; Merlino A.; The interaction of rhodium compounds with proteins: A structural overview. Coord Chem Rev  2021,442,213999","journal-title":"Coord Chem Rev"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"813","DOI":"10.3390\/ijms23020813","volume":"23","author":"Kacsir I.","year":"2022","unstructured":"Kacsir I.; Sipos A.; B\u00e9nyei A.; Janka E.; Bugly\u00f3 P.; Soms\u00e1k L.; Bai P.; Bokor \u00c9.; Reactive oxygen species production is responsible for antineoplastic activity of osmium, ruthenium, iridium and rhodium half-sandwich type complexes with bidentate glycosyl heterocyclic ligands in various cancer cell models. Int J Mol Sci  2022,23(2),813","journal-title":"Int J Mol Sci"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"102250","DOI":"10.1016\/j.cbpa.2022.102250","volume":"72","author":"L\u00f3pez-Hern\u00e1ndez J.E.","year":"2023","unstructured":"L\u00f3pez-Hern\u00e1ndez J.E.; Contel M.; Promising heterometallic compounds as anticancer agents: Recent studies in vivo. Curr Opin Chem Biol  2023,72,102250","journal-title":"Curr Opin Chem Biol"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1039\/C5DT02722E","volume":"45","author":"Schmidlehner M.","year":"2016","unstructured":"Schmidlehner M.; Flocke L.S.; Roller A.; Hejl M.; Jakupec M.A.; Kandioller W.; Keppler B.K.; Cytotoxicity and preliminary mode of action studies of novel 2-aryl-4-thiopyrone-based organometallics. Dalton Trans  2016,45(2),724-733","journal-title":"Dalton Trans"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.jorganchem.2018.07.035","volume":"872","author":"\u0160tarha P.","year":"2018","unstructured":"\u0160tarha P.; Dvo\u0159\u00e1k Z.; Tr\u00e1vn\u00ed\u010dek Z.; Half-sandwich Ir(III) and Rh(III) 2,2\u2032-dipyridylamine complexes: Synthesis, characterization and in vitro cytotoxicity against the ovarian carcinoma cells. J Organomet Chem  2018,872,114-122","journal-title":"J Organomet Chem"},{"key":"ref=83","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-031-35631-5","author":"Hussain A.","year":"2023","unstructured":"Hussain A.; Alajmi M.F.; Lone M.A.; Wani W.A.;  Therapeutic Rhodium Complexes  2023","journal-title":"Therapeutic Rhodium Complexes"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"151272","DOI":"10.1016\/j.scitotenv.2021.151272","volume":"806","author":"Kowalska J.","year":"2022","unstructured":"Kowalska J.; Biadu\u0144 E.; Ki\u0144ska K.; Gniadek M.; Krasnod\u0119bska-Ostr\u0119ga B.; Tracking changes in rhodium nanoparticles in the environment, including their mobility and bioavailability in soil. Sci Total Environ  2022,806(Pt 3),151272","journal-title":"Sci Total Environ"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"111400","DOI":"10.1016\/j.jinorgbio.2021.111400","volume":"218","author":"Peng Y.B.","year":"2021","unstructured":"Peng Y.B.; Tao C.; Tan C.P.; Zhao P.; Mitochondrial targeted rhodium(III) complexes: Synthesis, characterized and antitumor mechanism investigation. J Inorg Biochem  2021,218,111400","journal-title":"J Inorg Biochem"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"9330","DOI":"10.1039\/D4DT01082E","volume":"53","author":"Mitrovi\u0107 M.","year":"2024","unstructured":"Mitrovi\u0107 M.; Djuki\u0107 M.B.; Vuki\u0107 M.; Nikoli\u0107 I.; Radovanovi\u0107 M.D.; Lukovi\u0107 J.; Filipovi\u0107 I.P.; Mati\u0107 S.; Markovi\u0107 T.; Klisuri\u0107 O.R.; Popovi\u0107 S.; Matovi\u0107 Z.D.; Risti\u0107 M.S.; Search for new biologically active compounds: in vitro studies of antitumor and antimicrobial activity of dirhodium(II, II) paddlewheel complexes. Dalton Trans  2024,53(22),9330-9349","journal-title":"Dalton Trans"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"e202300200","DOI":"10.1002\/slct.202300200","volume":"8","author":"Amorello D.","year":"2023","unstructured":"Amorello D.; Orecchio S.; Barreca S.; Orecchio S.; Voltammetry for monitoring platinum, palladium and rhodium in environmental and food matrices. ChemistrySelect  2023,8(18),e202300200","journal-title":"ChemistrySelect"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/B978-0-12-822946-0.00025-8","author":"Iavicoli I.","year":"2022","unstructured":"Iavicoli I.; Leso V.;  In: Handbook on the Toxicology of Metals  2022,691-728","journal-title":"In: Handbook on the Toxicology of Metals"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1071\/EN22030","volume":"19","author":"Batley G.E.","year":"2022","unstructured":"Batley G.E.; Campbell P.G.C.; Metal contaminants of emerging concern in aquatic systems. Environ Chem  2022,19(1),23-40","journal-title":"Environ Chem"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.envint.2006.12.003","volume":"33","author":"Schmid M.","year":"2007","unstructured":"Schmid M.; Zimmermann S.; Krug H.F.; Sures B.; Influence of platinum, palladium and rhodium as compared with cadmium, nickel and chromium on cell viability and oxidative stress in human bronchial epithelial cells. Environ Int  2007,33(3),385-390","journal-title":"Environ Int"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"9068","DOI":"10.1039\/D1DT01053K","volume":"50","author":"Peng Y.B.","year":"2021","unstructured":"Peng Y.B.; He W.; Niu Q.; Tao C.; Zhong X.L.; Tan C.P.; Zhao P.; Mitochondria-targeted cyclometalated rhodium(III) complexes: synthesis, characterization and anticancer research. Dalton Trans  2021,50(26),9068-9075","journal-title":"Dalton Trans"},{"key":"ref=92","first-page":"1529","volume":"24","author":"Desoize B.","year":"2004","unstructured":"Desoize B.; Metals and metal compounds in cancer treatment. Anticancer Res  2004,24(3a),1529-1544","journal-title":"Anticancer Res"},{"key":"ref=93","first-page":"763","volume":"24","author":"Weber B.","year":"2004","unstructured":"Weber B.; Serafin A.; Michie J.; Van Rensburg C.; Swarts J.C.; Bohm L.; Cytotoxicity and cell death pathways invoked by two new rhodium-ferrocene complexes in benign and malignant prostatic cell lines. Anticancer Res  2004,24(2B),763-770","journal-title":"Anticancer Res"},{"key":"ref=94","first-page":"147","volume":"26","author":"Falzone N.","year":"2006","unstructured":"Falzone N.; B\u00f6hm L.; Swarts J.C.; Van Rensburg C.E.J.; Radiosensitization of CHO cells by two novel rhodium complexes under oxic and hypoxic conditions. Anticancer Res  2006,26(1A),147-152","journal-title":"Anticancer Res"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0009-2797(83)90037-6","volume":"45","author":"Sava G.","year":"1983","unstructured":"Sava G.; Giraldi T.; Mestroni G.; Zassinovich G.; Antitumor effects of rhodium(I), iridium(I) and ruthenium(II) complexes in comparison with cis-dichlorodiammino platinum(II) in mice bearing Lewis lung carcinoma. Chem Biol Interact  1983,45(1),1-6","journal-title":"Chem Biol Interact"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1007\/BF00304762","volume":"24","author":"Sava G.","year":"1989","unstructured":"Sava G.; Zorzet S.; Pacor S.; Mestroni G.; Zassinovich G.; Effects of two pyridinalalkyliminerhodium(I) complexes in mice bearing MCa mammary carcinoma. Cancer Chemother Pharmacol  1989,24(5),302-306","journal-title":"Cancer Chemother Pharmacol"},{"key":"ref=97","first-page":"781","volume":"9","author":"Craciunescu G.","year":"1989","unstructured":"Craciunescu G.; Scarcia V.; Furlani A.; Iglesias E.P.; Ghirvu C.; Papaioannou A.; Synthesis and biological evaluation of new Rh (I) complexes with sulfonamide derivatives. Anticancer Res  1989,9(3),781-785","journal-title":"Anticancer Res"},{"key":"ref=98","first-page":"329","volume":"5","author":"Craciunescu D.G.","year":"1991","unstructured":"Craciunescu D.G.; Scarcia V.; Furlani A.; Papaioannou A.; Parrondo Iglesias E.; Alonso M.P.; Pharmacological and toxicological studies on new Rh(I) organometallic complexes. In Vivo  1991,5(4),329-332","journal-title":"In Vivo"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"17871","DOI":"10.1002\/chem.201302819","volume":"19","author":"Oehninger L.","year":"2013","unstructured":"Oehninger L.; K\u00fcster L.N.; Schmidt C.; Mu\u00f1oz-Castro A.; Prokop A.; Ott I.; A chemical-biological evaluation of rhodium(I) N-heterocyclic carbene complexes as prospective anticancer drugs. Chemistry  2013,19(52),17871-17880","journal-title":"Chemistry"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"3281","DOI":"10.1021\/acs.inorgchem.9b03640","volume":"59","author":"Truong D.","year":"2020","unstructured":"Truong D.; Sullivan M.P.; Tong K.K.H.; Steel T.R.; Prause A.; Lovett J.H.; Andersen J.W.; Jamieson S.M.F.; Harris H.H.; Ott I.; Weekley C.M.; Hummitzsch K.; S\u00f6hnel T.; Hanif M.; Metzler-Nolte N.; Goldstone D.C.; Hartinger C.G.; Potent inhibition of thioredoxin reductase by the Rh derivatives of anticancer M (arene\/Cp*)(NHC)Cl2 complexes. Inorg Chem  2020,59(5),3281-3289","journal-title":"Inorg Chem"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"111721","DOI":"10.1016\/j.ejmech.2019.111721","volume":"183","author":"Fan R.","year":"2019","unstructured":"Fan R.; Bian M.; Hu L.; Liu W.; A new rhodium(I) NHC complex inhibits TrxR: In vitro cytotoxicity and in vivo hepatocellular carcinoma suppression. Eur J Med Chem  2019,183,111721","journal-title":"Eur J Med Chem"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/S1040-8428(01)00222-0","volume":"42","author":"Katsaros N.","year":"2002","unstructured":"Katsaros N.; Anagnostopoulou A.; Rhodium and its compounds as potential agents in cancer treatment. Crit Rev Oncol Hematol  2002,42(3),297-308","journal-title":"Crit Rev Oncol Hematol"},{"key":"ref=103","first-page":"2568","volume":"39","author":"Howard R.A.","year":"1979","unstructured":"Howard R.A.; Kimball A.P.; Bear J.L.; Mechanism of action of tetra-mu-carboxylatodirhodium(II) in L1210 tumor suspension culture. Cancer Res  1979,39(7 Pt 1),2568-2573","journal-title":"Cancer Res"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1107\/S010827019100032X","volume":"47","author":"Rubin J.R.","year":"1991","unstructured":"Rubin J.R.; Haromy T.P.; Sundaralingam M.; Structure of the anti-cancer drug complex tetrakis(\u03bc-acetato)-bis(1-methyl-adenosine)dirhodium(II) monohydrate. Acta Crystallogr C  1991,47(8),1712-1714","journal-title":"Acta Crystallogr C"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1021\/ja00084a093","volume":"116","author":"Dunbar K.R.","year":"1994","unstructured":"Dunbar K.R.; Matonic J.H.; Saharan V.P.; Crawford C.A.; Christou G.; Structural evidence for a new metal-binding mode for guanine bases: implications for the binding of dinuclear antitumor agents to DNA. J Am Chem Soc  1994,116(5),2201-2202","journal-title":"J Am Chem Soc"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0162-0134(95)00033-X","volume":"61","author":"Pruchnik F.","year":"1996","unstructured":"Pruchnik F.; Du\u015b D.; Properties of rhodium (II) complexes having cytostatic activity. J Inorg Biochem  1996,61(1),55-61","journal-title":"J Inorg Biochem"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S0162-0134(96)00065-7","volume":"65","author":"Pruchnik F.P.","year":"1997","unstructured":"Pruchnik F.P.; Kluczewska G.; Wilczok A.; Mazurek U.; Wilczok T.; Rhodium(II) complexes with phenanthrolines and their metabolic action on synchronized cell culture. J Inorg Biochem  1997,65(1),25-34","journal-title":"J Inorg Biochem"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1155\/MBD.1999.19","volume":"6","author":"Gil E.S.","year":"1999","unstructured":"Gil E.S.; Gon\u00e7alves M.I.A.; Ferreira E.I.; Zyngier S.B.; Najjar R.; Water soluble cyclophosphamide adducts of rhodium(II) keto-gluconate and glucuronate. Synthesis, characterization and in vitro cytostatic assays. Met Based Drugs  1999,6(1),19-24","journal-title":"Met Based Drugs"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1080\/09553008514551581","volume":"48","author":"Chibber R.","year":"1985","unstructured":"Chibber R.; Stratford I.J.; O\u2019Neill P.; Sheldon P.W.; Ahmed I.; Lee B.; The interaction between radiation and complexes of cis-Pt(II) and Rh(II): studies at the molecular and cellular level. Int J Radiat Biol Relat Stud Phys Chem Med  1985,48(4),513-524","journal-title":"Int J Radiat Biol Relat Stud Phys Chem Med"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/S0020-1693(97)05915-X","volume":"273","author":"Mestroni G.","year":"1998","unstructured":"Mestroni G.; Alessio E.; Sessanta o Santi, A.; Geremia, S.; Bergamo, A.; Sava, G.; Boccarelli, A.; Schettino, A.; Coluccia, M. Rhodium(III) analogues of antitumour-active ruthenium(III) compounds: The crystal structure of [ImH][trans-RhCl4(Im)2] (Im=imidazole). Inorg Chim Acta  1998,273(1-2),62-71","journal-title":"Inorg Chim Acta"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"4880","DOI":"10.1021\/acs.inorgchem.8b03477","volume":"58","author":"Liang J.","year":"2019","unstructured":"Liang J.; Levina A.; Jia J.; Kappen P.; Glover C.; Johannessen B.; Lay P.A.; Reactivity and transformation of antimetastatic and cytotoxic rhodium(III)\u2013dimethyl sulfoxide complexes in biological fluids: an XAS speciation study. Inorg Chem  2019,58(8),4880-4893","journal-title":"Inorg Chem"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.ejmech.2018.03.074","volume":"151","author":"Lu X.","year":"2018","unstructured":"Lu X.; Wu Y.M.; Yang J.M.; Ma F.E.; Li L.P.; Chen S.; Zhang Y.; Ni Q.L.; Pan Y.M.; Hong X.; Peng Y.; Preparation of Rhodium(III) complexes with 2(1H)-quinolinone derivatives and evaluation of their in vitro and in vivo antitumor activity. Eur J Med Chem  2018,151,226-236","journal-title":"Eur J Med Chem"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.31635\/ccschem.020.202000363","volume":"3","author":"Gul N.S.","year":"2021","unstructured":"Gul N.S.; Khan T.M.; Liu Y.C.; Choudhary M.I.; Chen Z.F.; Liang H.; Pd(II) and Rh(III) complexes with isoquinoline derivatives induced mitochondria-mediated apoptotic and autophagic cell death in HepG2 cells. CCS Chemistry  2021,3(6),1626-1641","journal-title":"CCS Chemistry"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"5373","DOI":"10.1021\/ic0498586","volume":"43","author":"Menon E.L.","year":"2004","unstructured":"Menon E.L.; Perera R.; Navarro M.; Kuhn R.J.; Morrison H.; Phototoxicity against tumor cells and Sindbis virus by an octahedral rhodium bisbipyridyl complex and evidence for the genome as a target in viral photoinactivation. Inorg Chem  2004,43(17),5373-5381","journal-title":"Inorg Chem"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1097\/CAD.0b013e32834850a5","volume":"22","author":"Kim M.R.","year":"2011","unstructured":"Kim M.R.; Morrison H.; Mohammed S.I.; Effect of a photoactivated rhodium complex in melanoma. Anticancer Drugs  2011,22(9),896-904","journal-title":"Anticancer Drugs"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1021\/ic401529u","volume":"53","author":"Almodares Z.","year":"2014","unstructured":"Almodares Z.; Lucas S.J.; Crossley B.D.; Basri A.M.; Pask C.M.; Hebden A.J.; Phillips R.M.; McGowan P.C.; Rhodium, iridium, and ruthenium half-sandwich picolinamide complexes as anticancer agents. Inorg Chem  2014,53(2),727-736","journal-title":"Inorg Chem"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3109\/07357908709020303","volume":"5","author":"McCully K.S.","year":"1987","unstructured":"McCully K.S.; Vezeridis M.P.; Antineoplastic activity of a rhodium trichloride complex of oxalyl homocysteine thiolactone. Cancer Invest  1987,5(1),25-30","journal-title":"Cancer Invest"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"4655","DOI":"10.1021\/bi990255t","volume":"38","author":"Jackson B.A.","year":"1999","unstructured":"Jackson B.A.; Alekseyev V.Y.; Barton J.K.; A versatile mismatch recognition agent: specific cleavage of a plasmid DNA at a single base mispair. Biochemistry  1999,38(15),4655-4662","journal-title":"Biochemistry"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1016\/j.jorganchem.2006.10.033","volume":"692","author":"Sch\u00e4fer S.","year":"2007","unstructured":"Sch\u00e4fer S.; Sheldrick W.S.; Coligand tuning of the DNA binding properties of half-sandwich organometallic intercalators: Influence of polypyridyl (pp) and monodentate ligands (L=Cl, (NH2)2CS, (NMe2)2CS) on the intercalation of (\u03b75-pentamethylcyclopentadienyl)-iridium(III)- dipyridoquinoxaline and -dipyridophenazine complexes. J Organomet Chem  2007,692(6),1300-1309","journal-title":"J Organomet Chem"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.1016\/j.jorganchem.2008.04.002","volume":"693","author":"Scharwitz M.A.","year":"2008","unstructured":"Scharwitz M.A.; Ott I.; Geldmacher Y.; Gust R.; Sheldrick W.S.; Cytotoxic half-sandwich rhodium(III) complexes: Polypyridyl ligand influence on their DNA binding properties and cellular uptake. J Organomet Chem  2008,693(13),2299-2309","journal-title":"J Organomet Chem"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1002\/ejic.201901055","volume":"2020","author":"Zhang W.Y.","year":"2020","unstructured":"Zhang W.Y.; Bridgewater H.E.; Banerjee S.; Soldevila-Barreda J.J.; Clarkson G.J.; Shi H.; Imberti C.; Sadler P.J.; Ligand\u2010controlled reactivity and cytotoxicity of cyclometalated rhodium(III) complexes. Eur J Inorg Chem  2020,2020(11-12),1052-1060","journal-title":"Eur J Inorg Chem"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.ejmech.2018.07.065","volume":"157","author":"P\u00e9rez-Arnaiz C.","year":"2018","unstructured":"P\u00e9rez-Arnaiz C.; Acu\u00f1a M.I.; Busto N.; Echevarr\u00eda I.; Mart\u00ednez-Alonso M.; Espino G.; Garc\u00eda B.; Dom\u00ednguez F.; Thiabendazole-based Rh(III) and Ir(III) biscyclometallated complexes with mitochondria-targeted anticancer activity and metal-sensitive photodynamic activity. Eur J Med Chem  2018,157,279-293","journal-title":"Eur J Med Chem"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.jorganchem.2015.10.008","volume":"801","author":"Kumar A.","year":"2016","unstructured":"Kumar A.; Kumar A.; Gupta R.K.; Paitandi R.P.; Singh K.B.; Trigun S.K.; Hundal M.S.; Pandey D.S.; Cationic Ru(II), Rh(III) and Ir(III) complexes containing cyclic -perimeter and 2-aminophenyl benzimidazole ligands: Synthesis, molecular structure, DNA and protein binding, cytotoxicity and anticancer activity. J Organomet Chem  2016,801,68-79","journal-title":"J Organomet Chem"},{"key":"ref=124","doi-asserted-by":"publisher","first-page":"108017","DOI":"10.1016\/j.inoche.2020.108017","volume":"118","author":"Liu J.H.","year":"2020","unstructured":"Liu J.H.; Pan F.H.; Wang Z.F.; Wang R.; Yang L.; Qin Q.P.; Tan M.X.; Synthesis, crystal structure and biological evaluation of three new Rh(III) complexes incorporating benzimidazole derivatives. Inorg Chem Commun  2020,118,108017","journal-title":"Inorg Chem Commun"},{"key":"ref=125","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.jinorgbio.2015.10.008","volume":"153","author":"Soldevila-Barreda J.J.","year":"2015","unstructured":"Soldevila-Barreda J.J.; Habtemariam A.; Romero-Canel\u00f3n I.; Sadler P.J.; Half-sandwich rhodium(III) transfer hydrogenation catalysts: Reduction of NAD+ and pyruvate, and antiproliferative activity. J Inorg Biochem  2015,153,322-333","journal-title":"J Inorg Biochem"},{"key":"ref=126","doi-asserted-by":"publisher","first-page":"11533","DOI":"10.1039\/c3cc46239k","volume":"49","author":"Yellol G.S.","year":"2013","unstructured":"Yellol G.S.; Donaire A.; Yellol J.G.; Vasylyeva V.; Janiak C.; Ruiz J.; On the antitumor properties of novel cyclometalated benzimidazole Ru(ii), Ir(iii) and Rh(iii) complexes. Chem Commun (Camb)  2013,49(98),11533-11535","journal-title":"Chem Commun (Camb)"},{"key":"ref=127","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/j.jinorgbio.2009.01.008","volume":"103","author":"Bieda R.","year":"2009","unstructured":"Bieda R.; Ott I.; Dobroschke M.; Prokop A.; Gust R.; Sheldrick W.S.; Structure\u2013activity relationships and DNA binding properties of apoptosis inducing cytotoxic rhodium(III) polypyridyl complexes containing the cyclic thioether [9]aneS3. J Inorg Biochem  2009,103(5),698-708","journal-title":"J Inorg Biochem"},{"key":"ref=128","doi-asserted-by":"publisher","first-page":"2463","DOI":"10.1039\/C7CC09384E","volume":"54","author":"Yang G.J.","year":"2018","unstructured":"Yang G.J.; Zhong H.J.; Ko C.N.; Wong S.Y.; Vellaisamy K.; Ye M.; Ma D.L.; Leung C.H.; Identification of a rhodium(III) complex as a Wee1 inhibitor against TP53 -mutated triple-negative breast cancer cells. Chem Commun (Camb)  2018,54(20),2463-2466","journal-title":"Chem Commun (Camb)"},{"key":"ref=129","doi-asserted-by":"publisher","first-page":"14609","DOI":"10.1002\/anie.202005758","volume":"59","author":"Hanif M.","year":"2020","unstructured":"Hanif M.; Arshad J.; Astin J.W.; Rana Z.; Zafar A.; Movassaghi S.; Leung E.; Patel K.; S\u00f6hnel T.; Reynisson J.; Sarojini V.; Rosengren R.J.; Jamieson S.M.F.; Hartinger C.G.; A multitargeted approach: organorhodium anticancer agent based on vorinostat as a potent histone deacetylase inhibitor. Angew Chem Int Ed  2020,59(34),14609-14614","journal-title":"Angew Chem Int Ed"},{"key":"ref=130","doi-asserted-by":"publisher","first-page":"4984","DOI":"10.1021\/ic100092d","volume":"49","author":"Leung S.K.","year":"2010","unstructured":"Leung S.K.; Kwok K.Y.; Zhang K.Y.; Lo K.K.W.; Design of luminescent biotinylation reagents derived from cyclometalated iridium(III) and rhodium(III) bis(pyridylbenzaldehyde) complexes. Inorg Chem  2010,49(11),4984-4995","journal-title":"Inorg Chem"},{"key":"ref=131","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1021\/acs.biochem.9b01037","volume":"59","author":"Nano A.","year":"2020","unstructured":"Nano A.; Bailis J.M.; Mariano N.F.; Pham E.D.; Threatt S.D.; Barton J.K.; Cell-selective cytotoxicity of a fluorescent rhodium metalloinsertor conjugate results from irreversible DNA damage at base pair mismatches. Biochemistry  2020,59(5),717-726","journal-title":"Biochemistry"},{"key":"ref=132","doi-asserted-by":"publisher","first-page":"6218","DOI":"10.1021\/ic990824l","volume":"38","author":"Jackson B.A.","year":"1999","unstructured":"Jackson B.A.; Henling L.M.; Barton J.K.; Spectral and structural characterization of 5, 6-chrysenequinone diimine complexes of rhodium (III): Evidence for a pH-dependent ligand conformational switch. Inorg Chem  1999,38(26),6218-6224","journal-title":"Inorg Chem"},{"key":"ref=133","doi-asserted-by":"publisher","first-page":"3737","DOI":"10.1073\/pnas.0537194100","volume":"100","author":"Junicke H.","year":"2003","unstructured":"Junicke H.; Hart J.R.; Kisko J.; Glebov O.; Kirsch I.R.; Barton J.K.; A rhodium(III) complex for high-affinity DNA base-pair mismatch recognition. Proc Natl Acad Sci USA  2003,100(7),3737-3742","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=134","doi-asserted-by":"publisher","first-page":"12986","DOI":"10.1021\/ja972489a","volume":"119","author":"Jackson B.A.","year":"1997","unstructured":"Jackson B.A.; Barton J.K.; Recognition of DNA base mismatches by a rhodium intercalator. J Am Chem Soc  1997,119(52),12986-12987","journal-title":"J Am Chem Soc"},{"key":"ref=135","doi-asserted-by":"publisher","first-page":"14160","DOI":"10.1021\/ja5072064","volume":"136","author":"Komor A.C.","year":"2014","unstructured":"Komor A.C.; Barton J.K.; An unusual ligand coordination gives rise to a new family of rhodium metalloinsertors with improved selectivity and potency. J Am Chem Soc  2014,136(40),14160-14172","journal-title":"J Am Chem Soc"},{"key":"ref=136","doi-asserted-by":"publisher","first-page":"5612","DOI":"10.1021\/jacs.8b02271","volume":"140","author":"Boyle K.M.","year":"2018","unstructured":"Boyle K.M.; Barton J.K.; A family of rhodium complexes with selective toxicity toward mismatch repair-deficient cancers. J Am Chem Soc  2018,140(16),5612-5624","journal-title":"J Am Chem Soc"},{"key":"ref=137","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1021\/acs.biochem.1c00302","volume":"60","author":"Nano A.","year":"2021","unstructured":"Nano A.; Dai J.; Bailis J.M.; Barton J.K.; Rhodium complexes targeting DNA mismatches as a basis for new therapeutics in cancers deficient in mismatch repair. Biochemistry  2021,60(26),2055-2063","journal-title":"Biochemistry"},{"key":"ref=138","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/j.jinorgbio.2011.04.006","volume":"105","author":"Hackenberg F.","year":"2011","unstructured":"Hackenberg F.; Oehninger L.; Alborzinia H.; Can S.; Kitanovic I.; Geldmacher Y.; Kokoschka M.; W\u00f6lfl S.; Ott I.; Sheldrick W.S.; Highly cytotoxic substitutionally inert rhodium(III) tris(chelate) complexes: DNA binding modes and biological impact on human cancer cells. J Inorg Biochem  2011,105(7),991-999","journal-title":"J Inorg Biochem"},{"key":"ref=139","doi-asserted-by":"publisher","first-page":"8094","DOI":"10.1039\/C4RA15649H","volume":"5","author":"Patalenszki J.","year":"2015","unstructured":"Patalenszki J.; B\u00edr\u00f3 L.; B\u00e9nyei A.C.; Muchova T.R.; Kasparkova J.; Bugly\u00f3 P.; Half-sandwich complexes of ruthenium, osmium, rhodium and iridium with DL -methionine or S-methyl- L -cysteine: a solid state and solution equilibrium study. RSC Advances  2015,5(11),8094-8107","journal-title":"RSC Advances"},{"key":"ref=140","doi-asserted-by":"publisher","first-page":"119265","DOI":"10.1016\/j.ica.2019.119265","volume":"501","author":"Aboura W.","year":"2020","unstructured":"Aboura W.; Batchelor L.K.; Garci A.; Dyson P.J.; Therrien B.; Reactivity and biological activity of N,N,S-Schiff-base rhodium pentamethylcyclopentadienyl complexes. Inorg Chim Acta  2020,501,119265","journal-title":"Inorg Chim Acta"},{"key":"ref=141","doi-asserted-by":"publisher","first-page":"5157","DOI":"10.1016\/j.ejmech.2010.08.028","volume":"45","author":"Rubner G.","year":"2010","unstructured":"Rubner G.; Bensdorf K.; Wellner A.; Bergemann S.; Ott I.; Gust R.; [Cyclopentadienyl]metalcarbonyl complexes of acetylsalicylic acid as neo-anticancer agents. Eur J Med Chem  2010,45(11),5157-5163","journal-title":"Eur J Med Chem"},{"key":"ref=142","doi-asserted-by":"publisher","first-page":"12016","DOI":"10.1039\/C9CC03822A","volume":"55","author":"Parveen S.","year":"2019","unstructured":"Parveen S.; Hanif M.; Leung E.; Tong K.K.H.; Yang A.; Astin J.; De Zoysa G.H.; Steel T.R.; Goodman D.; Movassaghi S.; S\u00f6hnel T.; Sarojini V.; Jamieson S.M.F.; Hartinger C.G.; Anticancer organorhodium and -iridium complexes with low toxicity in vivo but high potency in vitro: DNA damage, reactive oxygen species formation, and haemolytic activity. Chem Commun (Camb)  2019,55(80),12016-12019","journal-title":"Chem Commun (Camb)"},{"key":"ref=143","doi-asserted-by":"publisher","first-page":"6031","DOI":"10.3390\/molecules19056031","volume":"19","author":"Gupta G.","year":"2014","unstructured":"Gupta G.; Kumar J.; Garci A.; Nagesh N.; Therrien B.; Exploiting natural products to build metalla-assemblies: the anticancer activity of embelin-derived Rh(III) and Ir(III) metalla-rectangles. Molecules  2014,19(5),6031-6046","journal-title":"Molecules"},{"key":"ref=144","doi-asserted-by":"publisher","first-page":"10806","DOI":"10.1039\/b915357h","volume":"48","author":"Aguirre J.D.","year":"2009","unstructured":"Aguirre J.D.; Angeles-Boza A.M.; Chouai A.; Turro C.; Pellois J.P.; Dunbar K.R.; Anticancer activity of heteroleptic diimine complexes of dirhodium: A study of intercalating properties, hydrophobicity and in cellulo activity. Dalton Trans  2009,48(48),10806-10812","journal-title":"Dalton Trans"},{"key":"ref=145","doi-asserted-by":"publisher","first-page":"5371","DOI":"10.1021\/ic100588d","volume":"49","author":"Joyce L.E.","year":"2010","unstructured":"Joyce L.E.; Aguirre J.D.; Angeles-Boza A.M.; Chouai A.; Fu P.K.L.; Dunbar K.R.; Turro C.; Photophysical properties, DNA photocleavage, and photocytotoxicity of a series of dppn dirhodium(II,II) complexes. Inorg Chem  2010,49(12),5371-5376","journal-title":"Inorg Chem"},{"key":"ref=146","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1016\/j.jinorgbio.2009.08.003","volume":"103","author":"Ali Nazif M.","year":"2009","unstructured":"Ali Nazif M.; Bangert J.A.; Ott I.; Gust R.; Stoll R.; Sheldrick W.S.; Dinuclear organoiridium(III) mono- and bis-intercalators with rigid bridging ligands: Synthesis, cytotoxicity and DNA binding. J Inorg Biochem  2009,103(10),1405-1414","journal-title":"J Inorg Biochem"},{"key":"ref=147","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1016\/j.drudis.2009.09.003","volume":"14","author":"van Rijt S.H.","year":"2009","unstructured":"van Rijt S.H.; Sadler P.J.; Current applications and future potential for bioinorganic chemistry in the development of anticancer drugs. Drug Discov Today  2009,14(23-24),1089-1097","journal-title":"Drug Discov Today"},{"key":"ref=148","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1021\/ja8081044","volume":"131","author":"Ernst R.J.","year":"2009","unstructured":"Ernst R.J.; Song H.; Barton J.K.; DNA mismatch binding and antiproliferative activity of rhodium metalloinsertors. J Am Chem Soc  2009,131(6),2359-2366","journal-title":"J Am Chem Soc"},{"key":"ref=149","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.ccr.2015.10.007","volume":"309","author":"Furrer J.","year":"2016","unstructured":"Furrer J.; S\u00fcss-Fink G.; Thiolato-bridged dinuclear arene ruthenium complexes and their potential as anticancer drugs. Coord Chem Rev  2016,309,36-50","journal-title":"Coord Chem Rev"},{"key":"ref=150","doi-asserted-by":"publisher","first-page":"15457","DOI":"10.1039\/c3dt51991k","volume":"42","author":"Gupta G.","year":"2013","unstructured":"Gupta G.; Garci A.; Murray B.S.; Dyson P.J.; Fabre G.; Trouillas P.; Giannini F.; Furrer J.; S\u00fcss-Fink G.; Therrien B.; Synthesis, molecular structure, computational study and in vitro anticancer activity of dinuclear thiolato-bridged pentamethylcyclopentadienyl Rh(iii) and Ir(iii) complexes. Dalton Trans  2013,42(43),15457-15463","journal-title":"Dalton Trans"},{"key":"ref=151","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1021\/jm100020w","volume":"54","author":"Gasser G.","year":"2011","unstructured":"Gasser G.; Ott I.; Metzler-Nolte N.; Organometallic anticancer compounds. J Med Chem  2011,54(1),3-25","journal-title":"J Med Chem"},{"key":"ref=152","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jorganchem.2015.04.009","volume":"788","author":"Stringer T.","year":"2015","unstructured":"Stringer T.; Guzgay H.; Combrinck J.M.; Hopper M.; Hendricks D.T.; Smith P.J.; Land K.M.; Egan T.J.; Smith G.S.; Synthesis, characterization and pharmacological evaluation of ferrocenyl azines and their rhodium(I) complexes. J Organomet Chem  2015,788,1-8","journal-title":"J Organomet Chem"},{"key":"ref=153","doi-asserted-by":"publisher","first-page":"2544","DOI":"10.1021\/acs.inorgchem.5b02910","volume":"55","author":"Wenzel M.","year":"2016","unstructured":"Wenzel M.; de Almeida A.; Bigaeva E.; Kavanagh P.; Picquet M.; Le Gendre P.; Bodio E.; Casini A.; New luminescent polynuclear metal complexes with anticancer properties: toward structure\u2013activity relationships. Inorg Chem  2016,55(5),2544-2557","journal-title":"Inorg Chem"},{"key":"ref=154","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1021\/ic701518e","volume":"47","author":"Sharma S.","year":"2008","unstructured":"Sharma S.; Singh S.K.; Pandey D.S.; Ruthenium(II) polypyridyl complexes: potential precursors, metalloligands, and topo II inhibitors. Inorg Chem  2008,47(3),1179-1189","journal-title":"Inorg Chem"},{"key":"ref=155","doi-asserted-by":"publisher","first-page":"120918","DOI":"10.1016\/j.jorganchem.2019.120918","volume":"900","author":"Askari B.","year":"2019","unstructured":"Askari B.; Rudbari H.A.; Micale N.; Schirmeister T.; Maugeri A.; Navarra M.; Anticancer study of heterobimetallic platinum(II)-ruthenium(II) and platinum(II)-rhodium(III) complexes with bridging dithiooxamide ligand. J Organomet Chem  2019,900,120918","journal-title":"J Organomet Chem"},{"key":"ref=156","doi-asserted-by":"publisher","first-page":"11420","DOI":"10.1002\/anie.201204933","volume":"51","author":"Higgins S.L.H.","year":"2012","unstructured":"Higgins S.L.H.; Brewer K.J.; Designing red-light-activated multifunctional agents for the photodynamic therapy. Angew Chem Int Ed  2012,51(46),11420-11422","journal-title":"Angew Chem Int Ed"},{"key":"ref=157","doi-asserted-by":"publisher","first-page":"9786","DOI":"10.1039\/c1cc11562f","volume":"47","author":"Wang J.","year":"2011","unstructured":"Wang J.; Higgins S.L.H.; Winkel B.S.J.; Brewer K.J.; A new Os, Rh bimetallic with O2 independent DNA cleavage and DNA photobinding with red therapeutic light excitation. Chem Commun (Camb)  2011,47(35),9786-9788","journal-title":"Chem Commun (Camb)"},{"key":"ref=158","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/978-3-031-05494-5_36","author":"Guidoccio F.","year":"2022","unstructured":"Guidoccio F.; Mazzarri S.; Depalo T.; Orsini F.; Erba P.A.; Mariani G.;  Cham  2022,217-243","journal-title":"Cham"},{"key":"ref=159","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/S0969-8051(98)00109-7","volume":"26","author":"Brooks R.C.","year":"1999","unstructured":"Brooks R.C.; Carnochan P.; Vollano J.F.; Powell N.A.; Zweit J.; Sosabowski J.K.; Martellucci S.; Darkes M.C.; Fricker S.P.; Murrer B.A.; Metal complexes of bleomycin: evaluation of [Rh-105]-bleomycin for use in targeted radiotherapy. Nucl Med Biol  1999,26(4),421-430","journal-title":"Nucl Med Biol"},{"key":"ref=160","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1007\/s00775-009-0482-z","volume":"14","author":"Schmitt F.","year":"2009","unstructured":"Schmitt F.; Auzias M.; \u0160t\u011bpni\u010dka P.; Sei Y.; Yamaguchi K.; S\u00fcss-Fink G.; Therrien B.; Juillerat-Jeanneret L.; Sawhorse-type diruthenium tetracarbonyl complexes containing porphyrin-derived ligands as highly selective photosensitizers for female reproductive cancer cells. J Biol Inorg Chem  2009,14(5),693-701","journal-title":"J Biol Inorg Chem"}],"container-title":["Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0115734064327558240826050650","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/233528\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0115734064327558240826050650","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T07:41:55Z","timestamp":1759995715000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/233528\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":160,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0115734064327558240826050650","relation":{},"ISSN":["1573-4064"],"issn-type":[{"value":"1573-4064","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Double blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2024-05-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-07-21","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-08-05","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-26","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}